The second-line endocrine therapy landscape in hormone receptor (HR)-positive, HER2-negative advanced breast cancer is ...

The endocrine system plays a crucial role in regulating physiological processes and maintaining homeostasis. While previous ...

The U.S. Department of Health and Human Services released an update to its report on youth gender dysphoria treatments and ...

The Trump administration tapped critics of transition care to craft and peer review a scientific evaluation casting doubt on ...

Some cancer treatments can affect the body’s endocrine system, prompting CU Anschutz physicians to establish an endocrine-oncology clinic that helps patients get specialized care quickly.

The lidERA Breast Cancer study is a phase 3, randomized, open-label trial testing whether the adjuvant therapy giredestrant ...

Primary hyperparathyroidism (pHPT) was associated with long-term cardiometabolic risks, but the risk of type 2 diabetes was ...

Department of Health and Human Services report warns of risks from transgender medical procedures for children as Democrats ...

President Trump ordered the Department of Health and Human Services to compile the report in January, and a team of ...

The eight authors of the report are: Evgenia Abbruzzese, co-founder of the Society for Evidence-Based Gender Medicine Alex ...

Giredestrant significantly improves IDFS in ER-positive, HER2-negative early-stage breast cancer, surpassing standard ...

HHS report on trans care in youth rejects the use of gender-affirming procedures in favor of psychotherapy, while RFK Jr.